ClinicalTrials.gg
Drug

Benmelstobart clinical trials

Also written TQB2450.

studies test it
80
open now
45
in phase 3
17
first study started
2018

How each study uses benmelstobart is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the benmelstobart studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Benmelstobart
11
TQB2450 injection
6
benmelstobart combined with chemotherapy
2

Development codes

TQB2450
26

In one entry with another drug

Given together, or one or the other

benmelstobart combined with chemotherapy and anlotinib
2
Anlotinib and Benmelstobart
2

Studies by the year they started

80 studies that test it; most in 2026 (14)

Studies that test benmelstobart, by start year
YearStudies
20181
20198
202010
20217
20227
20239
202412
202512
202614

Who runs them

Industry 32 · Other 48

Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (30) · Sun Yat-sen University (4) · Henan Cancer Hospital (3) · The First Affiliated Hospital of Zhengzhou University (3) · Tianjin Medical University Cancer Institute and Hospital (3) · Fudan University (3) · Shanghai Pulmonary Hospital, Shanghai, China (3) · The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School (2)

Often tested with

Tested in the same studies.

Anlotinib (44) · Catequentinib hydrochloride (11) · Anti-HER2/Topoisomerase I Inhibitor ADC TQB2102 (2) · Vilzemetkib (1) · TLR7 Agonist JNJ-64794964 (1) · Tucidinostat (1) · Partial Nephrectomy (1) · Nimotuzumab (1)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 14, 1 in phase 3

Studies that test benmelstobart, phase 3 first.

Studies

Open first, then newest update. How each study uses benmelstobart is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 80

See all 80 studies that test benmelstobart →

Given beside what is tested · 7 — benmelstobart is usual care or a partner of the new treatment
As the comparator · 1 — what is tested is compared with benmelstobart

Codes

What other systems call benmelstobart · ClinicalTrials.gg INT016056

  • UNII (FDA) B25CF42QKPBENMELSTOBARTOne source FDA
  • NCI Thesaurus C156692BenmelstobartOne source FDA

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.